Reversal and protection against indomethacin-induced blood stasis and mucosal damage in the rat jejunum by a β3-adrenoceptor agonist

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 11, 1998, Pages 1121-1129

  Kelly, D ^a   Piasecki, C ^a   Anthony, A ^a   Dhillon, A P ^a   Pounder, R E ^a   Wakefield, A J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; INDOMETACIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY FLOW; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; HEMOSTASIS; HISTOLOGY; INTESTINE BLOOD FLOW; INTESTINE PERFUSION; INTESTINE VILLUS; INTRAVENOUS DRUG ADMINISTRATION; JEJUNUM DISEASE; JEJUNUM MUCOSA; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; BLOOD FLOW VELOCITY; DIOXOLES; FEMALE; GASTRIC MUCOSA; HEMOSTASIS; INDOMETHACIN; JEJUNAL DISEASES; MICROSCOPY, FLUORESCENCE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; STATISTICS, NONPARAMETRIC;

EID: 0031737523     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00400.x     Document Type: Article

References (38)

1. Somerville KW. Non-steroidal anti-inflammatory agents and the gastrointestinal tract. Postgrad Med J 1986; 62: 23-8.
2. Caruso I, Bianchi PG. Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1980; 20: 75-8.
3. Aabakken L, Osnes M. Non-steroidal anti-inflammatory drug-induced disease in the distal ileum and large bowel. Scand J Gastroenterol 1989; 24(Suppl. 163): 48-55.
4. Aabakken L. Non-steroidal anti-inflammatory drugs - the extending scope of gastrointestinal side effects. Aliment Pharmacol Ther 1992; 6: 143-62.
5. Rampton DS. Non-steroidal anti-inflammatory drugs and the lower gastrointestinal tract. Scand J Gastroenterol 1987; 22: 1-4.
6. Bjarnason I, Zanelli G, Prouse P, et al. Blood and protein loss via small intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet 1987; ii: 711-14.
7. Bjarnason I, Zanelli G, Prouse P, et al. Non-steroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987; 95: 480-9.
8. Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet 1991; 337: 520.
9. Morris AJ, Wasson LA, MacKenzie JF. Small bowel enteroscopy in diagnosed gastrointestinal blood loss. Gut 1992; 33: 887-9.
10. Anthony A, Dhillon AP, Nygard, et al. Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther 1995; 7: 29-10.
11. Kelly D, Piasecki C, Anthony A, Pounder RE, Wakefield AJ. Focal reduction of villous blood flow in early indomethacin enteropathy: a dynamic vascular study in the rat. Gut 1998; 42: 366-73.
12. Kuratani K, Kodama H, Yamaguchi I. Enhancement of gastric mucosal blood flow by beta-3 adrenergic agonists prevents indomethacin-induced antral ulcer in the rat. J Pharmacol Exp Ther 1994; 270: 1-7.
13. Berlan M, Galitzky J, Bousquet-Melou A, et al. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. J Pharmacol Exp Ther 1994; 268: 1444-51.
14. Shen YT, Zhang H, Vatner SF. Peripheral vascular effects of beta-3 adrenoceptor stimulation in conscious dogs. J Pharmacol Exp Ther 1994; 268: 466-73.
15. 3-adrenoceptor agonist induces increased pancreatic blood flow and insulin secretion in rats. Eur J Pharmacol 1996; 298: 287-92.
16. Takahashi H, Yoshida T, Nishimura M, et al. Beta-3 adrenergic agonist, BRL, OA, and alpha/beta blocker, arotinolol, markedly increase regional blood flow in brown adipose tissue in anaesthetised rats. Jpn Circ J 1992; 56: 956-42.
17. 3-adrenoceptor agonist CL 43 prevents indomethacin-induced jejunal ulceration in the rat by reversing early villous shortening. J Pathol 1996; 179: 340-6.
18. MacDonald A, Forbes IJ, Gallacher D, et al. Adrenoceptors mediating relaxation to catecholamines in rat isolated jejunum. Br J Pharmacol 1994; 112: 576-8.
19. 3-receptor. J Pharmacol Exp Ther 1995; 272: 446-51.
20. Bianchetti A, Manara L. In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical β-adrenoceptors in rat colon. Br J Pharmacol 1990; 100: 831-9.
21. Sarelius IH. Microcirculation in striated muscle after acute reduction in systemic hematocrit. Respir Physiol 1989; 78: 7-17.
22. Sarelius IH, Duling BR. Direct measurement of microvessel hematocrit, red cell flux, velocity and transit time. Am J Physiol 1982; 243: H1018-26.
23. Neff M, Metry JM, Frick P, Anliker M, Knoblauch M. The microvasculature of the small intestinal mucosa of the rat: Quantification of haemodynamic effects of topically applied Cimetidine, Ranitidine, Somatostatin and Vasopressin. Scand J Gastroenterol 1985; 112: 6-11.
24. Knoblauch M, Hollinger C. Microcirculalion studies on rat small intestinal villi in vivo. Schweiz Med Wochenschr 1977; 107: 1391-9.
25. Hollinger C, Radzyner M, Knoblauch M. Effects of glucagon, vasoactive intestinal peptide, and vasopressin on villous microcirculation and superior mesenteric artery blood flow in the rat. Gastroenterology 1985; 85: 1036-43.
26. Pries AR. A versatile video image analysis system for microcirculatory research. Int J Microcirc Clin Exp 1988; 7: 527-45.
27. Anthony A, Thrasivolou C, Pounder RE, Wakefield AJ, Dhillon AP. Mesenteric marginal ulceration: predilection for critically perfused areas in indomethacin-induced jejunal ulcers in the rat. Gut 1996; 38(Suppl. 1): F272.
28. Miller FN, Sims DE, Schuschke DA, Abney DL. Differentiation of light-dye effects in the microcirculation. Microvasc Res 1992; 44: 166-84.
29. Slaf DW, Arts T, Jeurens TJM, Tangelder GJ, Reneman RS. Electronic measurement of red blood cell velocity and volume flow in microvessels. Microvasc Res 1990; 40: 302-16.
30. Hucker HB, Zacchei AG, Cox SV, Brodie DA, Cantwell NHR. Studies on the absorption, distribution and excretion of indomethacin in various species. J Pharmacol Exp Ther 1966; 153: 237-49.
31. Yesair DW, Callahan L, Remington L, Kensler CJ. Role of the enterohepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeys. Biochem Pharmacol 1970; 19: 1579-90.
32. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gatroenterology 1993; 104: 1832-47.
33. Summers RJ, Russell FD, Roberts SJ. Localisation and characterisation of atypical β-adrenoceptors in skeletal muscle and gut. Pharmacol Commun 1995; 6: 237-52.
34. 3-adrenergic receptor. Eur J Biochem 1995; 224: 761-70.
35. 3-adrenoceptor in the human gastrointestinal tract. Gut 1997; 41(Suppl. 3): A144 (Abstract).
36. Wakefield AJ, Sawyerr AM, Dhillon AP. Pathogenesis of Crohn's disease: multifocal granulomatous infarction. Lancet 1989; ii: 1057-62.
37. Goulston SJM, McGovern VJ. The nature of benign strictures in ulcerative colitis. N Engl J Med 1969; 281: 290-5.
38. 3-adrenoceptor agonists - future anti-inflammatory drugs for the gastrointestinal tract. Aliment Pharmacol Ther 1996; 10: 859-63.